Live feed08:00:00·1576dSave storyPRReleasevia QuantisnowApplied Molecular Transport Announces Top-line Phase 2 Results from MARKET Combination Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative ColitisByQuantisnow·Wall Street's wire, on your screen.AMTIApplied Molecular Transport Inc.Health Care